Home   ->   news   ->   Press Releases

Press Releases

2017

News Archives: 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004

2017/10/09
WuXi AppTec Receives 2017 Global Integrated Drug R&D Services Competitive Strategy Innovation & Leadership Award from Frost & Sullivan

2017/09/14
WuXi NextCODE Appoints Rob Brainin EVP & Chief Operating Officer

2017/09/07
WuXi NextCODE Completes $240 Million Series B Financing

2017/07/31
WuXi’s Pharmaceutical Development Services Division Merges with STA

2017/07/24
STA Signs Supply Agreement with TESARO

2017/05/15
WuXi AppTec Completes Acquisition of HD Biosciences

2017/05/15
WuXi NextCODE AI Points to New Therapeutic Approaches to Cardiovascular Disease and Cancer in Yale Nature study

2017/05/02
WuXi NextCODE Raises $75 Million in Series B Financing to Accelerate Growth of Global Platform for Genomic Data

2017/03/30
WuXi Biologics Receives Asia-Pacific Best Bioprocessing Excellence Award from IMAPAC

2017/03/27
LabNetwork Integrates with Reaxys to Offer Seamless Experience from Chemistry Research to Purchase

2017/03/01
WuXi AppTec Lab Testing Division’s Bioanalytical Service Unit Passed FDA Inspection

2017/03/01
WuXi NextCODE Appoints Hannes Smarason as CEO, John Long as CFO, and Alex Fowkes as COO

2017/01/20
WuXi AppTec Acquires Biology Focused R&D Service Leader HD Biosciences

2017/01/18
Novel Anti-IL-6 Antibody for Rheumatoid Arthritis from WuXi–MedImmune Joint Venture Receives Clinical Trial Permit (CTP) from CFDA

2017/01/09
AbbVie, Genomics Medicine Ireland and WuXi NextCODE Announce Landmark Population Genomics Alliance

2017/01/05
WuXi NextCODE Selected as Genomics Platform for Singapore Precision Medicine Effort